Department of Chemistry and Biochemistry, University of the Sciences, 600 South 43rd Street, Philadelphia, PA, 19104, USA.
Department of Pharmaceutical Sciences, University of the Sciences, 600 South 43rd Street, Philadelphia, PA, 19104, USA.
Drug Test Anal. 2019 Aug;11(8):1144-1161. doi: 10.1002/dta.2608. Epub 2019 Jul 10.
A number of substances based on the 1,2-diarylethylamine template have been investigated for various potential clinical applications whereas others have been encountered as research chemicals sold for non-medical use. Some of these substances have transpired to function as NMDA receptor antagonists that elicit dissociative effects in people who use these substances recreationally. 1-[1-(2-Fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane, 2-F-DPPy) has recently appeared as a research chemical, which users report has dissociative effects. One common difficulty encountered by stakeholders confronting the appearance of new psychoactive substances is the presence of positional isomers. In the case of fluorolintane, the presence of the fluorine substituent on either the phenyl and benzyl moieties of the 1,2-diarylethylamine structure results in a total number of six possible racemic isomers, namely 2-F-, 3-F-, and 4-F-DPPy (phenyl ring substituents) and 2"-F-, 3"-F-, and 4"-F-DPPy (benzyl ring substituents). The present study reports the chemical syntheses and comprehensive analytical characterizations of the two sets of three positional isomers. These studies included various low- and high-resolution mass spectrometry platforms, gas- and liquid chromatography (GC and LC), nuclear magnetic resonance (NMR) spectroscopy and GC-condensed phase and attenuated total reflection infrared spectroscopy analyses. The differentiation between each set of three isomers was possible under a variety of experimental conditions including GC chemical ionization triple quadrupole tandem mass spectrometric analysis of the [M + H - HF] species. The latter MS method was particularly helpful as it revealed distinct formations of product ions for each of the six investigated substances.
许多基于 1,2-二芳基乙胺模板的物质已经被研究用于各种潜在的临床应用,而其他物质则被发现作为非医疗用途的研究化学品出售。其中一些物质被证明是 NMDA 受体拮抗剂,在娱乐性使用这些物质的人群中会引起分离效应。1-[1-(2-氟苯基)-2-苯乙基]吡咯烷(氟苯环利定,2-F-DPPy)最近作为一种研究化学品出现,使用者报告称其具有分离效应。利益相关者在面对新精神活性物质出现时遇到的一个常见困难是存在位置异构体。在氟苯环利定的情况下,氟取代基在 1,2-二芳基乙胺结构的苯基和苄基部分的存在导致总共存在六个可能的外消旋异构体,即 2-F-、3-F-和 4-F-DPPy(苯基环取代基)和 2"-F-、3"-F-和 4"-F-DPPy(苄基环取代基)。本研究报告了这两组三个位置异构体的化学合成和全面分析表征。这些研究包括各种低分辨率和高分辨率质谱平台、气相和液相色谱(GC 和 LC)、核磁共振(NMR)光谱以及 GC-凝聚相和衰减全反射红外光谱分析。在包括 GC 化学电离三重四极杆串联质谱分析 [M + H - HF] 物种在内的各种实验条件下,可以区分每组三个异构体。后者的 MS 方法特别有帮助,因为它揭示了对所研究的六种物质中的每一种物质的产物离子的独特形成。